SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-19-000019
Filing Date
2019-04-01
Accepted
2019-04-01 16:16:29
Documents
3
Period of Report
2019-03-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k_20190401umbrellapolicy.htm 8-K 43615
2 EXHIBIT 10.1 alpn-ex1001_20190401.htm EX-10.1 35904
3 EXHIBIT 10.2 alpn_ex1002x20190401.htm EX-10.2 25670
  Complete submission text file 0001626199-19-000019.txt   106643
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 19720890
SIC: 2834 Pharmaceutical Preparations